DWA
TRIB

Dorsey Wright & Associates’s Trinity Biotech TRIB Stock Holding History

Dorsey Wright & Associates’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1,611
Closed -$184K – 165
2014
Q1 		$184K Sell
1,611
-72
-4% -$9.44K 0.03% 116
2013
Q4 		$210K Buy
+1,683
New +$202K 0.03% 98
2013
Q3 		– Sell
-1,284
Closed -$108K – 133
2013
Q2 		$108K Buy
+1,284
New +$106K 0.02% 89

Other funds holding TRIB

HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
AAM
ACK Asset Management Greenwich, Connecticut $801M AUM 60.42% 1-Year Est. Return
CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
LSC
Lyon Street Capital Sausalito, California $67M AUM
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

Dorsey Wright & Associates's TRIB Position: Q2 2014 in Review

Dorsey Wright & Associates sold out of Trinity Biotech (TRIB) in Q2 2014, closing a stake of 1,611 shares — an estimated $184K sold.

Dorsey Wright & Associates first reported a position in TRIB in Q2 2013 and held it in 3 quarters. The position peaked at $210K in Q4 2013. 93 funds tracked by Wall St. Rank hold TRIB as of Q2 2014.

  • Dorsey Wright & Associates reported no remaining Trinity Biotech position as of Q2 2014 after selling out during the quarter.
  • Dorsey Wright & Associates sold 1,611 Trinity Biotech shares in Q2 2014, an estimated $184K.
  • Dorsey Wright & Associates first reported a position in Trinity Biotech in Q2 2013 and held it in 3 quarters.
  • Dorsey Wright & Associates's Trinity Biotech position peaked at $210K in Q4 2013.
  • 93 funds tracked by Wall St. Rank held Trinity Biotech as of Q2 2014.

Based on Dorsey Wright & Associates's 13F filing for Q2 2014, filed 29 Jul 2014.